(R)-(-)-1-Aminoindan | CAS:10277-74-4

We serve (R)-(-)-1-Aminoindan CAS:10277-74-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(R)-(-)-1-Aminoindan

Chemical Name:(R)-(-)-1-Aminoindan
CAS.NO:10277-74-4
Synonyms:(R)-(-)-1-Aminoindan
(1R)-2,3-dihydro-1H-inden-1-amine
(R)-2,3-Dihydro-1H-inden-1-amine
(R)-1-Aminoindane
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 225.0±19.0 °C at 760 mmHg
Melting Point 15ºC
Molecular Formula C9H11N
Molecular Weight 133.190
Flash Point 94.4±0.0 °C
 
Specification:
Appearance:Colorless to light yellow clear liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rasagiline Mesylate(CAS:161735-79-1).



Contact us for information like (R)-(-)-1-Aminoindan chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-1-Aminoindane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(R)-2,3-Dihydro-1H-inden-1-amine Use and application,(R)-1-Aminoindane technical grade,usp/ep/jp grade.


Related News: 1-Bromo-6-chlorohexane manufacturer According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.4-(3-bromophenyl)-2,6-diphenyl-pyrimidine supplier According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.2-Amino-3-fluorobenzoic Acid vendor Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.